Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infants and
is associated with increased mortality, respiratory morbidity, neurodevelopmental …

Bronchopulmonary dysplasia (BPD) is the most common cause of morbidity and mortality in
preterm infants. A key histopathological feature of BPD is stunted late lung development …

Bronchopulmonary dysplasia (BPD) remains the most common respiratory complication of
prematurity as younger and smaller infants are surviving beyond the immediate neonatal …

Oxygen therapy is common during the neonatal period to improve survival, but it can
increase the risk of oxygen toxicity. Hyperoxia can damage multiple organs and systems in …

Rationale: Bedside biomarkers that allow early identification of infants with
bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) are critically …

In the current era, the survival of extremely low-birth-weight infants has increased
considerably because of new advances in technology; however, these infants often develop …

An increasing number of extremely premature infants survive the neonatal period and
beyond. Little is known about the maturation of the preterm infant's metabolome and its …

Bronchopulmonary dysplasia (BPD) remains the most common complication of premature
birth, imposing a significant and potentially life-long burden on patients and their families …

Objective To identify new biomarkers of bronchopulmonary dysplasia (BPD) in preterm
neonates. Study design Metabolomic study of prospectively collected tracheal aspirate (TA) …

Background Birthweight reflects in utero exposures and later health evolution. Despite
existing studies employing high-dimensional molecular measurements, the understanding …